| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $67,957,972 ) (Continued on the next page) |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI168182 | Influence of the nasal microbiome on host susceptibility and response to respiratory viruses | 000 | 4 | NIH | 3/2/2026 | $686,339 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25AI189240 | Building Research and Implementation Capacity for Driving Growth and Equity (BRIDGE) Training Collaborative Program | 000 | 1 | NIH | 5/1/2026 | $376,266 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA266432 | Molecular Function and Mechanism of ARID4B in ERalpha Signaling and Breast Cancer | 000 | 5 | NIH | 7/17/2026 | $401,094 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | D43TW011952 | United States-Zambia Addressing Risk Factors for Non-Communicable Diseases (US-Zambia Risk NCD) | 002 | 5 | NIH | 2/19/2026 | $141,853 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | D43TW011952 | United States-Zambia Addressing Risk Factors for Non-Communicable Diseases (US-Zambia Risk NCD) | 001 | 5 | NIH | 2/9/2026 | $106,547 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS118197 | Understanding the effects of motor learning in wild-type and Mecp2-deficient mice | 000 | 5 | NIH | 3/25/2026 | $425,300 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21AI190737 | Genetic determinants of host immunity-mediated resistance to helminth infection | 000 | 1 | NIH | 2/3/2026 | $444,125 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25DA053141 | Scholars in HIV/AIDS Research Education (SHARE) | 000 | 5 | NIH | 7/6/2026 | $104,401 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HD106650 | A Longitudinal Study of Adversity, Stress Processes, and Health from Adolescence to Young Adulthood | 001 | 5 | NIH | 4/9/2026 | $668,812 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R37CA270536 | Understanding lactate catabolism by BACH1 in triple negative breast cancer | 000 | 5 | NIH | 8/4/2026 | $485,832 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R24AI152598 | The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC | 001 | 7 | NIH | 6/18/2026 | $6,161,120 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS126090 | Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells | 000 | 6 | NIH | 6/26/2026 | $231,575 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P20ES036775 | Research and Engagement for Action on Climate and Health (REACH) Center | 001 | 3 | NIH | 8/17/2026 | $1,195,966 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R21CA292195 | Tobacco use trajectories and related mechanisms among US adults and youth | 000 | 2 | NIH | 5/7/2026 | $188,753 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 003 | 6 | NIH | 7/7/2026 | $21,103 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 002 | 6 | NIH | 6/5/2026 | $0 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 001 | 6 | NIH | 4/20/2026 | $872,805 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 000 | 6 | NIH | 12/23/2025 | $792,461 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124123 | TNFR2 sex differences and EAE | 001 | 5 | NIH | 3/5/2026 | $40,375 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124123 | TNFR2 sex differences and EAE | 000 | 5 | NIH | 12/17/2025 | $363,375 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01HD114633 | Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial | 000 | 2 | NIH | 7/3/2026 | $3,106,769 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01AR079717 | Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection | 001 | 4 | NIH | 5/14/2026 | $58,606 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U01AR079717 | Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection | 000 | 4 | NIH | 3/10/2026 | $1,054,927 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AG073474 | MWAS+ – A Novel Drug Repurposing Strategy for ADRD Prevention | 000 | 5 | NIH | 6/9/2026 | $643,040 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01MH129169 | RCT of a parent-focused intervention to reduce HIV risk in adolescent MSM | 000 | 5 | NIH | 3/19/2026 | $670,128 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL133100 | Leptin and intermittent hypoxia interactions in the carotid bodies: mechanisms and consequences | 001 | 10 | NIH | 7/9/2026 | $698,306 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS106244 | Thalamic contributions to the developing EEG | 000 | 8 | NIH | 4/17/2026 | $453,429 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $160,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $200,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $40,150 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $164,934 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $45,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $40,150 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $40,150 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $115,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $45,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $40,150 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $130,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 001 | 12 | NIH | 8/25/2026 | $50,000 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 002 | 13 | NIH | 9/3/2026 | $143,742 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 001 | 13 | NIH | 9/2/2026 | $56,808 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 000 | 13 | NIH | 8/24/2026 | $148,653 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS051709 | TNF in Injury and Repair Processes Following Traumatic SCI | 000 | 19 | NIH | 7/22/2026 | $494,226 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DA054751 | Recreational Marijuana Marketing and Young Adult Consumer Behavior | 000 | 5 | NIH | 2/20/2026 | $691,867 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HD107427 | Effects of a non-nutritive sweetener reduction intervention in pregnancy and lactation on maternal and infant outcomes (the SWEETPEA trial) | 000 | 3 | NIH | 2/27/2026 | $662,577 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HD107427 | Effects of a non-nutritive sweetener reduction intervention in pregnancy and lactation on maternal and infant outcomes (the SWEETPEA trial) | 001 | 3 | NIH | 5/1/2026 | $0 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI183533 | mRNA-LNP vaccines targeting multiple stages and multiple species of human malaria parasite | 000 | 2 | NIH | 12/5/2025 | $795,296 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01EY022730 | Circuit specializations of developing visual networks | 000 | 13 | NIH | 8/25/2026 | $588,600 |
| | 2026 | 2026 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA288337 | The role of And-1 in R-loop and endocrine resistance in breast cancer | 001 | 2 | NIH | 4/16/2026 | $54,241 |
|
